Companies: 10,795·Total market cap: $144.5T
Enovis Corporation

Enovis Corporation

ENOVNYSEHealthcare● Active
$23.90
+$0.12(+0.48%)
Market Cap$1.4B
P/E Ratio
52W High$36.82
52W Low$20.82
Overview

Enovis Corporation (ENOV) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

enov · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
3
Sell
0
Strong Sell
0
Total: 13 · Buy rate: 76.9%

12-Month Price Target

High

$52.00

Consensus

$45.80

+90.4% upside

Low

$36.00

Median: $50 · Last Close: $24.05

The Enovis Corporation (ENOV) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month ENOV price target is $45.80, representing +90.4% upside from the current price of $24.05.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $46 (90.4%)

Consensus Target

$45.80

90.4% upside

High Target

$52

116.2%

Low Target

$36

49.7%

Current Price

$24.05

as of today

Based on analyst price targets, the ENOV stock price prediction for the next 12 months ranges from $36 to $52. The consensus ENOV price forecast of $45.80 implies 90.4% upside from the current price of $24.05.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$23.193.60%

1-day model range: $23.02–$23.36. Peak: $23.36 (-3.60%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$16-35.1%
2028$13-47.6%
2029$11-53.2%
2030$11-55.9%
2031-57.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)43.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ENOV · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$22.84BUY
MA 10$22.90BUY
MA 20$24.11SELL
MA 50$24.06SELL
MA 100$23.60BUY
MA 200$26.73SELL
Current $ENOV · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$23.27BUY
EMA 10$23.29BUY
EMA 20$23.67BUY
EMA 50$23.98BUY
EMA 100$24.58SELL
EMA 200$26.74SELL
Current $ENOV · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BTIG2026-05-22
Maintains
BuyBuy
Evercore ISI Group2026-05-08
Maintains
OutperformOutperform
Wells Fargo2026-05-08
Maintains
OverweightOverweight
Evercore ISI Group2026-04-06
Maintains
OutperformOutperform
Needham2026-02-26
Maintains
BuyBuy
BTIG2026-02-26
Maintains
BuyBuy
Canaccord Genuity2025-12-17
Maintains
BuyBuy
Wells Fargo2025-11-07
Maintains
OverweightOverweight
Wells Fargo2025-08-08
Maintains
OverweightOverweight
UBS2025-08-08
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Enovis Corporation (ENOV) stock. Of the recent 49 rating actions, 1 were upgrades and 1 were downgrades. 13 analysts currently cover ENOV.

Analyst Recommendation Trends

Buy ratings431
Hold ratings00
Sell ratings00

ENOV analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.1B

↓ 10.5% YoY

Revenue Next Year

$2.3B

↑ 7.3% YoY

EPS This Year

$2.78

EPS Next Year

$3.20

↑ 15.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ENOV EPS of $2.78 for the current fiscal year, based on estimates from 7 analysts. The ENOV revenue forecast is $2.1B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ENOV stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ENOV price target is $45.80 (+90.4% upside), with an analyst consensus of Buy.

The ENOV short-term stock prediction for tomorrow is $23.19 (-3.60%). The ENOV stock price prediction for 2027 estimates an average of $16. The ENOV stock prediction for 2030 projects a range of $10–$11.

Enovis Corporation trades on NYSE under the ticker ENOV. The ENOV stock outlook for 2027 is broadly positive, supported by a Buy consensus among 77% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ENOV forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month ENOV price target is $45.80, with a high forecast of $52.00 and a low of $36.00. The median price target is shown in the chart above when available. This implies +90.4% potential upside from the current price of $24.05.

ENOV price targetWhat is ENOV price targetENOV analyst price targetENOV 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.